Main > INFLUENZA VIRUS > Infection. Treatment > Respiratory Congestion Redn. > Neuraminidase Inhibitor. > H1 Histamine R Antagonist Combi. > Oseltamivir.+ > H1 Histamine R Antagonist Combi. > Patent. > Claims > Claim 1: Dual Release Drug Delivery > Device: 1) Compn.: Oseltamivir & > Excipient; Controlled Release & 2) > H1 Histamine Receptor Antagonist; > Rapid Release. Claim 2: Device > Select: Capsules Etc. Claim 4: > (1): Release Rate Modifier. Claim 5 > : (2): Excipient. Claim 12: Osmotic > Device: a) Core: Oseltamivir (Granu > late) & Osmotic Agent; b) SemiPerme > able Membrane having Passageway > & c) Coat.: H1 Antagonist. Claim > 13: Inert Water Soluble Coat (d) > between (b) & (c). Claim 14: (c) > Sprayed onto (d). Claim 19:

---

Sprayed onto (d). Claim 19:'s subsections
H1 Antagonist Select: Acrivastine;

Sprayed onto (d). Claim 19:'s products
This section has no products